SLC6A12 blocking peptide product blog
Tags: Blocking Peptide; Slc6a12; SLC6A12 blocking peptide; S6A12;
The SLC6A12 slc6a12 (Catalog #MBS9217640) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase.The SLC6A12 slc6a12 product has the following accession number(s) (GI #171184404) (NCBI Accession #NP_003035.3) (Uniprot Accession #P48065). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Transports betaine and GABA. May have a role in regulation of GABAergic transmission in the brain through the reuptake of GABA into presynaptic terminals, as well as in osmotic regulation.
Cellular Location: Membrane; Multi-pass membrane protein. Tissue Location: Liver, heart, skeletal muscle, placenta, and a widespread distribution in the brain. SLC6A12 also interacts with the following gene(s): NFAT5, SLC1A1, SLC1A3, SLC5A3. Brain, Eye, Intestine, Kidney, Liver, Lung tissues are correlated with this protein. Cell Transformation, Neoplastic, Disease Models, Animal, Drug-Related Side Effects and Adverse Reactions, Heart Diseases, Kidney Diseases, Learning Disorders, Liver Diseases, Nervous System Diseases, Neurobehavioral Manifestations, Seizures are some of the diseases may be linked to S6A12 Antibody (N-term) Blocking Peptide. The following patways have been known to be associated with this gene.